参考文献/References:
［1］Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 ［J］. International journal of cancer,2015，136(5):E 359-386.
［2］Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis ［J］. Cochrane Database Syst Rev, 2010(1):CD008285.
［3］Datta NR, Stutz E, Liu M, et al. Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervix cancer: A systematic review and meta-analysis ［J］. Gynecol Oncol,2017,145(2):374-85.
［4］Zuliani AC, Esteves SC, Teixeira LC, et al. Concomitant cisplatin plus radiotherapy and high-dose-rate brachytherapy versus radiotherapy alone for stage IIIB epidermoid cervical cancer: a randomized controlled trial ［J］. J Clin Oncol,2014;32(6):542-547.
［5］Shrivastava S, Mahantshetty U, Engineer R, et al. Cisplatin Chemoradiotherapy vs Radiotherapy in FIGO Stage IIIB Squamous Cell Carcinoma of the Uterine Cervix: A Randomized Clinical Trial ［J］. JAMA oncology,2018,4(4):506-513.
［6］Ryu SY, Lee WM, Kim K, et al. Randomized clinical trial of weekly vs. triweekly cisplatin-based chemotherapy concurrent with radiotherapy in the treatment of locally advanced cervical cancer ［J］. Int J Radiat Oncol Biol Phys, 2011,81(4):e 577-581.
［7］Rydzewska L, Tierney J, Vale CL, et al. Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer ［J］. Cochrane Database Syst Rev,2012,12:CD007406.
［8］Gupta S, Maheshwari A, Parab P, et al. Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial ［J］. J Clin Oncol, 2018,36(16):1548-1555.
［9］Kitagawa R, Katsumata N, Shibata T, et al. Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505 ［J］. J Clin Oncol,2015,33(19):2129-2135.
［10］Mori T, Makino H, Okubo T, et al. Multi-institutional phase II study of neoadjuvant irinotecan and nedaplatin followed by radical hysterectomy and the adjuvant chemotherapy for locally advanced, bulky uterine cervical cancer: A Kansai Clinical Oncology Group study (KCOG-G1201) ［J］. The journal of obstetrics and gynaecology research,2018.
［11］Tanioka M, Yamaguchi S, Shimada M, et al. Cisplatin with dose-dense paclitaxel before and after radical hysterectomy for locally advanced cervical cancer: a prospective multicenter phase II trial with a dose-finding study ［J］. Medical oncology (Northwood, London, England), 2017,34(8):134.
［12］Sun H, Huang K, Tang F, et al. Adjuvant chemotherapy after surgery can improve clinical outcomes for patients with IB2-IIB cervical cancer with neoadjuvant chemotherapy followed by radical surgery ［J］. Scientific reports,2018,8(1):6443.
［13］Gadducci A, Landoni F, Cosio S, et al. Neoadjuvant Platinum-based Chemotherapy Followed by Radical Hysterectomy for Stage Ib2-IIb Adenocarcinoma of the Uterine Cervix - An Italian Multicenter Retrospective Study ［J］. Anticancer Res,2018,38(6):3627-3634.
［14］Zhu Y, Yang J, Zhang X, et al. Acquired treatment response from neoadjuvant chemotherapy predicts a favorable prognosis for local advanced cervical cancer: A meta-analysis ［J］. Medicine,2018,97(17):e 0530.
［15］Marita A, Ordeanu C, Rancea A, et al. Long-term survival following neoadjuvant chemotherapy and concomitant radiochemotherapy in locally advanced cervical cancer: results of the Oncology Institute "Prof. Dr. Ion Chiricuta" experience ［J］. J Med Life, 2018,11(1):42-50.
［16］McCormack M, Kadalayil L, Hackshaw A, et al. A phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancer ［J］. Br J Cancer, 2013,108(12):2464-2469.
［17］Morice P, Rouanet P, Rey A, et al. Results of the GYNECO 02 study, an FNCLCC phase III trial comparing hysterectomy with no hysterectomy in patients with a (clinical and radiological) complete response after chemoradiation therapy for stage IB2 or II cervical cancer ［J］. Oncologist,2012,17(1):64-71.
［18］Ma Y, Zhao G, Qi J, et al. Neoadjuvant brachytherapy and chemotherapy followed by radical surgery for stage IB2 and IIA cervical cancer: A retrospective comparison with chemoirradiation ［J］. Molecular and clinical oncology, 2018,8(4):623-627.
［19］Ferrandina G, Palluzzi E, Gallotta V, et al. Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study ［J］. Eur J Surg Oncol,2018,44(7):1062-1068.
［20］Gadducci A, Barsotti C, Laliscia C, et al. Dose-dense Paclitaxel- and Carboplatin-based Neoadjuvant Chemotherapy Followed by Surgery or Concurrent Chemo-radiotherapy in Cervical Cancer: a Preliminary Analysis ［J］. Anticancer Res,2017,37(3):1249-1255.
［21］Duenas-Gonzalez A, Zarba JJ, Patel F, et al. Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix ［J］. J Clin Oncol,2011,29(13):1678-1685.
［22］Tangjitgamol S, Katanyoo K, Laopaiboon M, et al. Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer ［J］. Cochrane Database Syst Rev,2014(12):CD010401.
相似文献/References:
[1]周萍,李秀美,江彩虹,等.妊娠合并卵巢肿瘤98例临床分析[J].中国计划生育和妇产科,2010,(02):0.
[2]王晓银,庄琳.老年妇科肿瘤临床特点分析[J].中国计划生育和妇产科,2014,(05):0.
WANG Xiao-yin,ZHUANG lin,Maternal and Child Health Hospital of Sichuan Province,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(6):0.
[3]刘飞飞,田泉,王丽莎,等.耐药性绒癌2例病例报道及文献复习[J].中国计划生育和妇产科,2015,(12):0.
LIU Fei-fei,TIAN Quan,WANG Li-sha,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2015,(6):0.
[4]张凌焱,杨建华*.弥漫性子宫平滑肌瘤病1例报道并文献复习[J].中国计划生育和妇产科,2017,(12):67.
ZHANG Ling-yan,YANG Jian-hua*.A case report of diffuse uterine leiomyomatosis and review of the literature[J].Chinese Journal of Family Planning & Gynecotokology,2017,(6):67.
[5]张小芹,李萌,卢美松*.辅助生殖技术中子宫肌瘤的管理策略[J].中国计划生育和妇产科,2019,(7):6.
[6]肖维,戴河柳,曹文雅,等.亮丙瑞林联合腹腔镜保守手术对卵巢子宫内膜异位症患者体内相关内分泌代谢和远期预后的影响[J].中国计划生育和妇产科,2019,(8):66.
XIAO Wei,DAI He-liu,CAO Wen-ya,et al.Effect of leuprolide combined with laparoscopic conservative operation on related endocrine metabolism and long-term prognosis in patients with ovarian endometriosis[J].Chinese Journal of Family Planning & Gynecotokology,2019,(6):66.